Effect of ranitidine on theophylline metabolism in healthy Koreans living in China.
To evaluate the effect of concurrent ranitidine therapy on theophylline metabolism in healthy Koreans. A 4-week, double-blind, randomized, placebo-controlled, crossover study. The Clinical Research Unit, Department of Pharmaceutical Sciences, Yanbian Medical College, Yanji, China. Six young, healthy, nonsmoking Korean volunteers residing in China with no known factors that would alter theophylline metabolism. Subjects received extended-release oral theophylline at a constant dosage over 4 weeks to yield a serum concentration (Cp) between 5 and 10 micrograms/mL. Week 1 was the dosage titration phase. During week 2 subjects randomly received either ranitidine or a matching placebo. Week 3 was a washout phase, and during week 4 subjects were crossed over to receive either placebo or ranitidine. At the end of each treatment week, serum and urinary metabolite concentrations were measured. Theophylline serum concentrations and urinary concentrations of 1-methylxanthine, 1-methyluric acid, 3-methylxanthine, and 1,3-dimethyluric acid were measured. Estimates of clearance (Cl), volume of distribution (Vd), and half-life (t1/2) were determined. Concurrent administration of ranitidine with theophylline did not significantly alter theophylline Cp, Cl, Vd, or t1/2. Urinary concentrations of major theophylline metabolites also were not changed. Ranitidine does not significantly alter the metabolism of theophylline in healthy Koreans residing in China.